Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pfeffer

Showing results (511-520 of 908) with videos related to

Pageof 91
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 15, 2017
Robust lysosomal calcium signaling through channel TRPML1 is impaired by lysosomal lipid accumulationNéstor Más Gómez, Wennan Lu, Jason C Lim, et al.
European Journal of Heart Failure|September 3, 2019
Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failureStefano Coiro, Nicolas Girerd, Abhinav Sharma, et al.
European Journal of Heart Failure|January 27, 2009
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) programLarry A Allen, G Michael Felker, Stuart Pocock, et al.
JAMA|July 24, 1991
Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE InvestigatorsM A Pfeffer, L A Moyé, E Braunwald, et al.
The American Journal of Cardiology|June 29, 2004
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)Satish Kenchaiah, Marc A Pfeffer, Martin St John Sutton, et al.
Circulation|September 1, 1995
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement InvestigatorsG A Lamas, G C Flaker, G Mitchell, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 22, 2008
Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) TrialAndrew G Bostom, Myra A Carpenter, Lawrence Hunsicker, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 7, 2012
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarctionAlessandra Meris, Maria Amigoni, Anil Verma, et al.
The American Journal of Cardiology|March 15, 1995
Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levelsF M Sacks, J L Rouleau, L A Moye, et al.
Circulation|October 1, 1986
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansionR G McKay, M A Pfeffer, R C Pasternak, et al.
Pageof 91

Showing results (511-520 of 908) with videos related to

Sort By:
Pageof 91
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 15, 2017
Robust lysosomal calcium signaling through channel TRPML1 is impaired by lysosomal lipid accumulationNéstor Más Gómez, Wennan Lu, Jason C Lim, et al.
European Journal of Heart Failure|September 3, 2019
Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failureStefano Coiro, Nicolas Girerd, Abhinav Sharma, et al.
European Journal of Heart Failure|January 27, 2009
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) programLarry A Allen, G Michael Felker, Stuart Pocock, et al.
JAMA|July 24, 1991
Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE InvestigatorsM A Pfeffer, L A Moyé, E Braunwald, et al.
The American Journal of Cardiology|June 29, 2004
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)Satish Kenchaiah, Marc A Pfeffer, Martin St John Sutton, et al.
Circulation|September 1, 1995
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement InvestigatorsG A Lamas, G C Flaker, G Mitchell, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 22, 2008
Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) TrialAndrew G Bostom, Myra A Carpenter, Lawrence Hunsicker, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 7, 2012
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarctionAlessandra Meris, Maria Amigoni, Anil Verma, et al.
The American Journal of Cardiology|March 15, 1995
Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levelsF M Sacks, J L Rouleau, L A Moye, et al.
Circulation|October 1, 1986
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansionR G McKay, M A Pfeffer, R C Pasternak, et al.
Pageof 91